Same old story

Commentary

Same old story

If venture capital firms are truly revamping their company startup models, the message of change in the industry doesn't seem to have seeped through to the startups themselves.

At the recent meeting of the Oxford BioScience Partners/Ernst & Young National Conference on Biotechnology Ventures, we were struck by the bland uninformativeness of the vast majority of the presentations we heard. With

Read the full 651 word article

How to gain access

Continue reading with a
two-week free trial.